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The Epstein–Barr virus (EBV) encoded nuclear antigens, EBNA-3, -4, and -6 (EBNA 3 family) are expressed in latently
infected human B-cells and are involved in the transformation of lymphocytes by EBV. Human Burkitt’s lymphoma (BL) dG75
cells which stably expressed either the complete EBNA 3 gene family or the vector alone were generated and changes in
gene activity in these transfectants were assayed using the differential display of mRNA technique. For the first time, the
human gene pleckstrin, which is thought to be involved in signalling and differentiation of hemopoietic cells, was found to
be upregulated in the presence of the EBNA 3 protein family, but not in cells expressing the individual EBNA-3, -4, or -6
gene. Pleckstrin was increased up to sevenfold in different cell clones and the bulk culture of EBNA 3 gene family expressing
cells as demonstrated by Northern blot, RT-PCR, and immunoblot. In contrast to EBV-negative BL cells, pleckstrin RNA and
protein were highly expressed in EBV growth transformed lymphoblastoid cell lines which are thought to play an important
role in EBV persistence in vivo. These data suggest that induction of pleckstrin might be important for the EBV-controlled
activation of cells and offers a unique biological system for analyzing pleckstrin function. q 1996 Academic Press, Inc.
INTRODUCTION Parker, 1994) suggested a role as transcriptional regula-
tors. Indeed, expression of the individual genes of the
Epstein–Barr virus (EBV) is associated with a variety
EBNA 3 family resulted in transactivation or repression
of human diseases including infectious mononucleosis,
of promoters and genes including viral LMP-1, TP-1, and
Burkitt’s lymphoma (BL), nasopharyngeal carcinoma, and
cellular CD21, CD23, CD40, CD77, and vimentin (Allday
Hodgkin’s disease. After primary infection, EBV estab-
et al., 1993; LeRoux et al., 1994; Marshall and Sample,
lishes a lifelong persistent infection which is thought to
1995; Silins et al., 1994; Wang et al., 1990). EBNA-6 con-
be primarily controlled by EBV-specific cytotoxic T-cells
tains a basic leucine zipper motif (Allday et al., 1993) and
(reviewed in (Rickinson et al., 1992)). The oncogenic po-
was shown to form stable complexes with the cellular
tential of EBV is reflected in its ability to efficiently trans-
DNA-binding factor RBP-Jk leading to inhibition of EBNA-
form and immortalize human B-cells in vitro. The resulting
2-mediated promoter activation (Marshall and Sample,
latently infected lymphoblastoid cell lines (LCLs) express
1995; Robertson et al., 1995).
a restricted set of EBV genes including six nuclear anti-
Knowledge about the repertoire of EBV-induced cellu-
gens (EBNA-1 through EBNA-6), three latent membrane
lar genes is important for understanding EBV-controlled
proteins (LMP-1, TP-1, TP-2), and two small nuclear RNAs
cell growth. To further address the impact that the EBNA
(EBER 1-2) (reviewed in (Kieff et al., 1991)).
3 family genes have on the expression of cellular genes,
The EBNA-3, EBNA-4, and EBNA-6 genes (also known
we generated BL cells stably expressing the complete
as EBNA-3a, -3b, -3c, or EBNA 3 family) share a similar
EBNA 3 family and analyzed the transfectants for
genomic organization (Fig. 1A) and have structural and
changes in gene expression using the differential display
sequence homologies at the protein level (LeRoux et al.,
of mRNA (DDRT-PCR) technique (Liang and Pardee,
1994). The persistent expression of the EBNA 3 family
1992). Using this approach, we demonstrate that expres-
genes against negative selective pressure by cytotoxic
sion of the cellular pleckstrin gene product is upregu-
T-cells in vivo (Rickinson et al., 1992) is consistent with
lated in cells expressing the EBNA 3 family of genes.
an important role for these genes. Although it was shown
that EBNA-3 and EBNA-6 were essential for B cell immor-
MATERIALS AND METHODStalization (Tomkinson et al., 1993), little is known about
the function of these genes. Their nuclear localization Cell lines
and DNA-binding activity (Kallin et al., 1986; Sample and
BL30A (Lenoir et al., 1985) and dG75 (Ben Bassat et
al., 1977) are EBV-negative Burkitt’s lymphoma cells. B95-1 To whom correspondence and reprint requests should be ad-
8 (Arrand et al., 1984) and WW2-LCL (Rooney et al., 1984)dressed at Queensland Institute of Medical Research, Post Office,
are EBV-positive lymphoblastoid cell lines (LCLs). CellsRoyal Brisbane Hospital, Brisbane 4029 Qld Australia. Fax: 61-7-
33620106. E-mail: norbertK@qimr.edu.au. were maintained in RPMI 1640 medium supplemented
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with 10% fetal calf serum, benzylpenicillin (0.7 mg/ml), quots of the RNA preparation were stored at 0707 in the
presence of RNase inhibitor and dithiothreitol. Storedand streptomycin (1 mg/ml) at 377 in a 5% CO2 atmo-
sphere. samples were used for differential display of mRNA and
reverse transcriptase polymerase chain reaction.
Plasmid constructs
Differential display of mRNA (DDRT-PCR) analysisThe EBNA 3 family open reading frames (ORFs) were
derived from the M-ABA HindIIIE clone pACYC184-H3E
DDRT-PCR was performed essentially as described by(Polack et al., 1984) and the cloning sites used are illus-
Liang and Pardee (1992) incorporating recently pub-trated in Fig. 1A. To construct the EBNA-346 expression
lished modifications (Liang and Pardee, 1995). RNA sam-vector, a 12.5-kbp HindIII fragment of pACYC184-H3E,
ples from clones and bulk cultures of the EBNA 3 genewhich contains the complete EBNA 3 gene family, was
family expressing cells (EE346) and vector controlligated into the mammalian expression vector EBO-pLPP
transfectants were analyzed in parallel. Four reversepreviously digested with HindIII. The 10.5-kbp shuttle
transcription reactions (20 ml) for each RNA sample werevector EBO-pLPP (Margolskee et al., 1988) contains the
performed at 427 for 50 min using 2.5 mM of dT12MA,oriP/EBNA-1 replicon for episomal maintenance of the
dT12MC, dT12MG, or dT12MT (where M is degenerate forvector, the hygromycin resistance gene for eukaryotic
A, C, and G), 300 ng of purified total RNA, 20 mM ofselection, and an SV40 transcription-cassette. To prepare
each deoxynucleoside triphosphate (dNTP), and 200 Uthe EBNA-3 expression vector, a 3.5-kbp HindIII– CelII
of SuperScript-II enzyme (GibcoBRL). The reaction wasfragment that contains the EBNA-3 ORFs was subcloned
terminated by incubation at 957 for 5 min. The samplesfrom pACYC184-H3E and ligated into a HindIII– NotI
were then incubated with 1.5 U of RNaseH (Promega)(Klenow treated) digest of EBO-pLPP. Construction of the
for 30 min at 377. The RNaseH was inactivated by incuba-EBNA-6 expression plasmid required the 5.4-kbp AfllII–
tion at 957 for 5 min. The samples were either immedi-HindIII (Klenow treated) fragment of pACYC184-H3E to
ately subjected to PCR or stored at 0207.be ligated into the XbaI-restricted, end-filled EBO-pLPP.
PCR amplifications (20 ml) were performed in PCRThe generation of the EBNA-4 expression vector con-
buffer containing 0.5 mM of an arbitrary 10-mer primer,taining the ScaI– XbaI fragment of pACYC184-H3E was
2 ml of each first strand cDNA sample, 2 mM each ofdescribed recently (Silins et al., 1994).
dCTP, dGTP, and dTTP, 1 mM dATP, 2.5 mM of the re-
spective dT12MN (M  A, C, or G; N  A, C, G, or T), 0.3Cell transfection
ml (3 mCi; 2000 Ci/mmol) of [a-33P]dATP (DuPont), and
Transfection of dG75 cells with the recombinant ex- 2.5 U of AmpliTaq DNA polymerase (Perkin–Elmer). The
pression vectors was performed as recently outlined (Sil- ice-chilled samples were transferred to a 9600 GeneAmp
ins et al., 1994) using lipofectin-mediated transfer of the PCR Instrument System (Perkin–Elmer), preheated at
plasmid DNA. Surviving cell clones and heterogenous 857, and subjected to an initial denaturation at 947 for 1
bulk cultures were selected and maintained in medium min. This was followed by 40 cycles of denaturation at
containing 500–600 mg/ml hygomycin B (Boehringer 947 for 30 sec, primer annealing at 427 for 1 min, and
Mannheim). primer extension at 727 for 30 sec, and then a final exten-
sion at 727 for 5 min. Five microliters of DNA tracking
RNA purification
buffer (TaqTrack Stop Solution, Promega) was added and
the samples were heated to 957 for 2 min prior to electro-Total RNA was prepared from 5–10 1 106 exponen-
tially growing cells using either of two commercially phoresis on a 6% polyacrylamide-urea sequencing gel.
To evaluate the product size, cDNA fragments, whichavailable RNA kits which were based on the guanidinium
thiocyanate purification method (RNAgents Total RNA were generated and radiolabeled by RT-PCR, were
loaded in parallel. Gels were electrophoresed at 55 WIsolation System, Promega; Total RNA Isolation Reagent,
Advanced Biotechnologies). RNA (40 mg) was incubated constant current, dried without fixation under vacuum at
807 for 1 hr, covered with plastic wrap, and exposed towith 30 U of RNase-free DNaseI (Boehringer Mannheim)
in the presence of PCR buffer (10 mM Tris–HCl, pH 8.3; Kodak T-Mat G film for 1 to 3 days at room temperature.
DNA bands were recovered from the gel by excision,50 mM KCl; 1.5 mM MgCl2), 40 U of RNase-inhibitor
(Boehringer Mannheim), and 5 mM dithiothreitol for 50 resuspended in 50 ml of water, and DNA was eluted by
boiling for 20 min. Six-microliter samples were subjectedmin at 377 in a total volume of 80 ml. The RNA was
finally purified by a phenol/chloroform step followed by to PCR reamplication (30-ml assay, 40 cycles) using the
appropriate primers and conditions described above, ex-isopropanol precipitation. The DNaseI treatment was
crucial for the removal of episomal-based DNA as pre- cept for the omission of the radioisotope and that dNTP
concentrations of 20 mM were used. The DNA from theviously reported (Kienzle et al., 1996). The purity of the
RNA was determined by absorbance at A260/280 and its total sample was separated by electrophoresis on a 3%
agarose gel containing ethidium bromide in TAE-bufferintegrity was verified on a formamide-agarose gel. Ali-
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(40 mM Tis-acetate; 1 mM EDTA, pH 8.0), recovered from scribed previously (Kienzle et al., 1996) except for the
addition of 50 mCi of each [a-32P]dATP and [a-32P]dCTPthe gel, purified by GeneClean (BIO 101), and finally
cloned into pGEM-T (Promega). (3000 Ci/mmol, DuPont) and that 25 mM of dGTP and
dTTP and 6.3 mM of dATP and dCTP were used. TheSequencing of the cloned DNA was performed using
the DyeDeoxy terminator cycle sequencing kit (Applied radiolabeled pleckstrin probe was directly added to the
membrane preincubated for 1 hr in prehybridizationBiosystems) with the M13 forward primer. The sequence
reaction was analyzed on an ABI 373A DNA sequencing buffer (50% formamide, 51 SSPE, 51Denhardt’s solution,
0.5% SDS, 20 mg/ml salmon sperm DNA) and hybridizedsystem (Applied Biosytems). The resulting DNA se-
quences were matched against the GeneBank database at 427 overnight. The filter was washed two times in 21
SSPE, 0.1% SDS at room temperature for 10 min, andusing the GCG program FASTA (Devereux et al., 1984).
then washed once in 11 SSPE, 0.1% SDS at 427 for 15
Reverse transcriptase polymerase chain reaction (RT- min and finally subjected to a high stringency wash in
PCR) analysis 0.11 SSPE, 0.1% SDS at 427 for 10 min. The blot was
exposed to a Kodak Storage Phosphor Screen at room
Conditions of the RT-PCR assay were previously
temperature for 1–3 days and the signals were analyzed
described in detail (Kienzle et al., 1996). Briefly, total
on a PhosphorImager 400B system (Molecular Dynam-
RNA was reverse transcribed using oligo-dT primers,
ics). The filter was stripped by washing three times in
dNTPs, and SuperScript-II enzyme, and the resulting
boiling 0.1% SDS for 30 min each and finally reprobed
cDNA/RNA hybrids were subjected to alkaline hydroly-
with the radiolabeled b-actin probe.
sis and purified. For RT-negative controls the Super-
Script-II enzyme was omitted. For the amplification of
pleckstrin the primers Pleck-F (5*-AAGGGAGCACTC- Immunoblot analysis
TGACTAGCC-3*) and Pleck-R (5*-ACATGTCTCCAG-
Cells were washed in phosphate-buffered saline (PBS)CAGGCTG-3*) were used generating a 439-bp-long
and lysed by dispensing in sample buffer (2% SDS; 5%cDNA fragment (Fig. 3). As a control for the RT-PCR, b2-
a-Monothioglycerol; 10% glycerol; 60 mM Tris–HCl, pHmicroglobulin (b2-M) was amplified using the primers
6.8; 0.001% bromophenol blue) with sonication and then5*-CCCCCACTGAAAAAGATGAG-3* and 5*-TCACTC-
boiling for 5 min. Samples were subjected to SDS–poly-AATCCAAATGCGGC-3*, generating a 131-bp product.
acrylamide gel electrophoresis and electrotransferredThe b2-M control was used as there are no pseudo
onto nitrocellulose filters (Amersham) using a minigelgenes of b2-M leading to false positive signals or com-
system (Bio-Rad). Filters were stained with Ponceau Spetition effects (Matthes et al., 1993).
(Sigma) to confirm the presence of even amounts of pro-PCR amplification was performed as described re-
tein and were then preincubated for 1.5 hr in Blotto buffercently (Kienzle et al., 1996) except that 22 cycles were
(PBS, 0.1% Tween 20, 5% skim milk, 1% BSA). For detec-used and primers were annealed at 607. The amplified
tion of the EBNA proteins filters were incubated with thecDNAs were separated by electrophoresis on 2.5% aga-
EBV-positive human serum MCr (1/50 diluted in Blotto)rose gels containing ethidium bromide in TAE-buffer. The
for 1 hr at room temperature. Pleckstrin protein was de-gel was photographed under UV light using a Polaroid
tected using a 1/4000 dilution of a polyclonal rabbit anti-T-55 film and the relative amount of each DNA band was
pleckstrin serum (Abrams et al., 1995). Filters werequantified using a Computing Densitometer 300B system
washed four times for 10 min each in PBS–0.1% Tween(Molecular Dynamics).
20 and were then incubated for 1 hr with either horserad-
ish peroxidase-conjugated sheep anti-human IgG (Amer-Northern blot analysis
sham) or horseradish peroxidase-conjugated sheep anti-
Total RNA (15 mg) was electrophoresed on a 1% aga- rabbit IgG (Silenus) at a 1/1000 dilution. The filters were
rose-formaldehyde gel in MOPS/EDTA-buffer (20 mM washed as outlined above and the reactions visualized
Mops [3-(N-morpholino)propanesulfonic acid]; 5 mM so- using the ECL Western blotting detection system (Amer-
dium acetate; 1 mM EDTA, pH 7.0) at 55 V (constant sham). The relative amount of each protein band was
voltage). After electrophoresis, the RNA was transferred quantified using a Computing Densitometer 300B system
to a Hybond-N membrane (Amersham) by capillary blot- (Molecular Dynamics).
ting and fixed onto the membrane by heating at 807 for
2 h under vacuum. Radiolabeled DNA probes of pleck-
strin and b-actin were generated by PCR amplification RESULTS
of either the E14A-2/pGEM-T plasmid using the M13 for-
ward/reverse primers or oligo-dT reverse-transcribed Generation of cell transfectants
cDNA from vector-transfected dG75 cells (E-bulk) using
the b-actin specfic primers p5*Ac and p3*Ac (Uematsu, As outlined under Materials and Methods, expres-
sion vectors coding for the EBNA 3 family genes (Fig.1991). The reactions (100 ml) were performed as de-
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1A) were constructed and stably introduced into the
human, EBV-negative BL cell line dG75. Transfected
cells containing the EBNA-3, EBNA-4, EBNA-6, or the
complete EBNA 3 family constructs were designated
EE3, EE4, EE6, or EE346, respectively. Control cells
(E) were transfected with the vector alone. To avoid
artefacts due to clonal variation, heterogenous bulk
cultures as well as cell clones were independently
generated in multiple experiments. The generation of
the EBNA-4 expressing dG75 clones has previously
been described (Silins et al., 1994).
To demonstrate that clones and bulk cultures of the
transfectants were expressing the EBNA proteins, im-
munoblot analysis was used (Fig. 1B). The expression
of a 140-kDa EBNA-3 protein was detected in EE3
cultures whereas a 165-kDa EBNA-4 protein was
present in the EE4 cells; two forms (155/170 kDa) of
FIG. 2. Upregulation of pleckstrin RNA. (A) Differential display of
mRNA (DDRT-PCR). Total RNA was reverse transcribed using the
dT12MA primer, and PCR amplified using the OPD-14 and dT12MA prim-
ers. The cDNAs were separated on a sequencing gel and visualized
by autoradiography. E-bulk (lane 1), EE346-bulk (lane 2), E-C3 (lane 3),
EE346-G7 (lane 4). A part of the autoradiograph is shown. The size
and position of the upregulated cDNA E14A-2 is indicated. (B) Northern
blot. Total RNA was prepared from E-bulk (lane 1) and EE346-bulk
(lane 2) cultures and was hybridized with either a radiolabeled, PCR-
amplified pleckstrin probe (E14A-2) or b-actin. The positions of ribo-
somal RNA are indicated on the left. Hybridization to pleckstrin and b-
actin are indicated by arrows. The scan ratio indicates the hybridization
signal strength between lanes 1 and 2.
the EBNA-6 gene were detected in EE6 clones. Each
gene of the EBNA 3 family was expressed at similar
levels in the EE346 cells and cells containing the indi-
vidual EBNA-3, -4, or -6 genes. Interestingly, under the
culture conditions used, the EBNA-6 proteins could
only be detected in cell clones but not in bulk cultures
of EBNA-6 transfectants (the experiment was repeated
three times). All transfectants expressed a 75-kDa
EBNA-1 protein encoded by the vector.
Pleckstrin RNA is induced by the EBNA 3 gene family
The DDRT-PCR approach was used to screen the
EE346 and vector control cells for deregulated gene ex-
FIG. 1. The EBNA 3 family genes of the EBV strain M-ABA. (A) The pression. The combination of the 5*-arbitrary primer 5*-
genomic organization of the EBV HindIII-E region encompassing the
CTTCCCCAAG-3* (OPD-14, Operon) and the anchoropen reading frames of EBNA-3, EBNA-4, and EBNA-6 is illustrated.
primer dT12MA generated a cDNA fragment which wasThe sites of the restriction enzymes used for cloning are shown and
the numbers refer to the B95.8 sequence (Baer et al., 1984). (B) Immu- overexpressed in clone EE346-G7 and in the bulk culture
noblot. Cell extracts of the parental dG75 line as well as of cell clones of EE346 cells compared to the vector control (Fig. 2A).
or bulk cultures expressing the vector EBO-pLPP only (E), EBNA-3 Due to the denaturing conditions of the sequencing gel,
(EE3), EBNA-4 (EE4), EBNA-6 (EE6), or the complete EBNA 3 family
low molecular weight products are separated into both(EE346) were analyzed with an EBV-positive human serum. The posi-
DNA strands. The upper band of the upregulated cDNAtions of the EBNA proteins are indicated by arrows and size markers
(kDa) are shown on the left. designated E14A-2 was recovered from the gel and
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when compared to the vector control (Fig. 4A, lanes 5
and 7). The parental dG75 cells had lower levels of pleck-
strin RNA than the vector control (Fig. 4A, lane 1), which
might have been due to an effect of the hygromycin selec-
tion or the EBNA-1 protein (encoded from the transfer
vector). Bulk cultures of the transfectants, expressing
only EBNA-3 or EBNA-4, and clone EE6-F11 displayed
pleckstrin RNA levels similar to the vector control cells
(Fig. 4A, lanes 2–4, 6, 8). Northern blot analysis was
performed to confirm the RT-PCR data using the cloned
pleckstrin cDNA fragment as a probe. As demonstrated
in Fig.4B, pleckstrin RNA levels (after normalization to
the b-actin control) were 3.9-fold higher in the EE346
transfectants compared to the vector control or parental
cell line. In contrast, the individual EBNA-3, EBNA-4, andFIG. 3. Schematic diagram of pleckstrin RNA. The 2.745-kb pleckstrin
mRNA and its coordinates (GenBank Accession No. X07743) are pic- EBNA-6 transfectants revealed only a 1.6- to 2.4-fold in-
tured. The open box represents the open reading frame encompassing crease in pleckstrin RNA. Taken together, the RT-PCR
bp 61 to bp 1113, coding for a 350 amino acids protein. The zoomed and Northern blot data suggested that the upregulation
area shows the sequence homology between E14A-2 cDNA and a
of pleckstrin RNA may have been due to the coordinatesection of the 3*-untranslated region of human pleckstrin (labelled
action of all three of the EBNA 3 gene family products.hsple). The boxed sections indicate the primers used in DDRT-PCR.
The two arrowheads mark the region amplified by RT-PCR using primer
pair Pleck-F/Pleck-R (bp 211 to bp 649). Detection of upregulated pleckstrin protein
To determine whether increases in pleckstrin RNA were
cloned into pGEM-T. Sequencing and a computerized reflected at the protein level, expression of pleckstrin was
homology analysis of the 125-bp-long E14A-2 cDNA re-
vealed a nearly perfect match to human pleckstrin RNA.
Pleckstrin is the acronym for platelet and leucocyte C
kinase substrate which is thought to be involved in sig-
nalling and differentiation of hemopoietic cells (Tyers et
al., 1988). As illustrated in Fig. 3, E14A-2 is part of the 3*-
untranslated region of the 2.7-kb-long pleckstrin mRNA
coding for a protein of 350 amino acids. The 5*-arbitrary
primer matched in 7 of 10 bases with the pleckstrin se-
quence and the 3*-anchor primer matched in 13 of 14
bases with a poly(A) region located within the 1.6-kb-
large 3* untranslated mRNA region.
To confirm that pleckstrin RNA was upregulated in the
EE346 transfectants, Northern blot analysis was per-
formed using the cloned pleckstrin cDNA fragment E14A-
2 as a probe. The probe hybridized to an 3-kb RNA
species in the EE346 bulk culture (Fig. 2B, left part), which
was similar in size to that previously reported for pleck-
strin mRNA in differentiating HL-60 cells (Tyers et al.,
1989). Normalization of the intensity of the pleckstrin
band to the b-actin control revealed a fourfold increase FIG. 4. Coordinate expression of pleckstrin RNA in EE346 cells. (A)
RT-PCR. Total RNA was reverse transcribed and b2-microglobulin (b2-in EE346 cells compared to vector control cells (Fig. 2B).
M, 131 bp) and pleckstrin (439 bp) were PCR amplified, separated onTo analyze whether EBNA-3, -4, or -6 by itself could
a agarose gel, and quantified. The pleckstrin signals were standardizedupregulate pleckstrin expression, RT-PCR with the indi-
to b2-M and expressed as mean pleckstrin values (resulting from at
vidual EE3, EE4, and EE6 transfectants was used. A pro- least three experiments). dG75 (lane 1), EE3-bulk (lane 2), EE4-bulk
tocol for reproducible amplification of cDNA fragments (lane 3), EE6-F11 (lane 4), EE346-bulk (lane 5), E-bulk (lane 6), EE346-
G7 (lane 7), E-C3 (lane 8). (B) Northern blot. Total RNA was preparedof pleckstrin and the housekeeping gene b2-M was es-
from dG75 (lane 1), E-bulk (lane 2), EE346-bulk (lane 3), EE3-bulk (lanetablished under nonsaturated low PCR cycle numbers.
4), EE4-bulk (lane 5), and EE6-F11 (lane 6) cultures and was hybridizedNo amplified products of pleckstrin or b2-M were present
with either a radiolabeled, PCR-amplified pleckstrin probe (E14A-2) or
in the RT-negative controls (data not shown). Clone b-actin probe. Hybridization to pleckstrin and b-actin are indicated.
EE346-G7 and the bulk culture of EE346 had a 3.5- to 4- The pleckstrin signals were standardized to b-actin and expressed in
relative units.fold (normalized to b2-M) increase in pleckstrin RNA
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cal situation in EBV-infected cells in which all three EBNA
genes are normally expressed. Furthermore, B-cells ex-
pressing the LCL-like pattern of viral latent gene expres-
sion has been detected ex vivo in humans (Tierney et
al., 1994) and this strongly suggests that the virus-driven
expansion of B-cells is important for EBV persistence in
vivo. As different EE346 clones as well as the EE346 bulk
culture, which is a heterogenous population of uncloned
cell transfectants, demonstrated similar amounts of
pleckstrin RNA and protein, upregulation of pleckstrin
due to clonal variation could be ruled out. Surprisingly,
FIG. 5. Detection of pleckstrin protein by immunoblot. Cell extracts the individual EBNA-3, -4, and -6 transfectants showedwere prepared and pleckstrin was detected by immunoblot using an
no increase of pleckstrin levels, indicating that the coor-anti-pleckstrin rabbit serum. EE346-D7 (lane 1), E-bulk (lane 2), EE3-
dinate expression of at least two and maybe all three ofbulk (lane 3), EE346-G7 (lane 4), EE346-bulk (lane 5), EE4-bulk (lane
6), EE346-D5 (lane 7), dG75 (lane 8), BL30A (lane 9), B95–8 (lane 10), the EBNA proteins was needed to cause an upregulation
and WW2-LCL (lane 11). The position of pleckstrin is indicated by an of pleckstrin.
arrow and size markers (kDa) are shown on the left. In our study, there appeared to be a direct correlation
between the expression levels of pleckstrin mRNA and
protein as measured by RT-PCR and immunoblot. Previ-measured by immunoblot using a polyclonal anti-pleckstrin
ous results on differentiating HL-60 cells also showedserum which reacts with the 40-kDa pleckstrin protein
that protein abundance paralleled the mRNA levels of(Abrams et al., 1995). A five- to sevenfold increase in pleck-
pleckstrin (Tyers et al., 1989). These data indicate thatstrin protein was observed in different EE346 cell cultures
the regulation of pleckstrin expression takes place at thecompared to the vector control while the bulk cultures of
level of transcription and/or RNA processing. While theEE3 and EE4 cells as well as clone EE6-F11 expressed
mechanism of EBNA-induced pleckstrin expression islevels of pleckstrin similar to the vector control (Fig. 5, lanes
unclear at present, there is evidence suggesting that1–7, and Table 1) which was consistent with the RT-PCR
EBNA-3, -4, and -6 can act as transcriptional modulators.and Northern blot data.
The EBNA-3, -4, and -6 proteins share structural homolo-Analysis of the EBV-positive LCLs B95-8 and WW2-
gies and all three proteins can individually counteractLCL, both of which express the EBNA 3 family genes,
transactivation of the TP-1 promoter by EBNA-2 (Le Rouxrevealed high levels of pleckstrin protein expression, es-
et al., 1994). Expression of the EBNA-4 and EBNA-6pecially when compared to the EBV-negative BL cell lines
genes has been shown to result in either upregulationBL30A and dG75 in which pleckstrin was undetectable
or repression of cellular CD21, CD23, CD40, CD77, vi-(Fig. 5, lanes 8–11, and Table 1). In addition, RT-PCR
mentin, and viral LMP-1 (Allday et al., 1993; Silins etanalysis revealed upregulated pleckstrin RNA levels in
al., 1994; Wang et al., 1990). EBNA-3 and EBNA-6 arethe LCLs but not in the EBV-negative cells (data not
shown).
TABLE 1DISCUSSION
Pleckstrin Protein Expression in B-Lymphocytes
DDRT-PCR is a recently developed method for analyz-
Cells Pleckstrina EBVing changes in cellular gene expression (reviewed in
(Liang and Pardee, 1995)). Application of DDRT-PCR to
E-C3 1 EBNA-1EE346 cell lines, stably transfected with the EBNA 3 fam-
E-E2 1 EBNA-1
ily of genes, identified an upregulated RNA species that E-bulk 1 EBNA-1
was shown to encode human pleckstrin. Analysis of the EE346-G7 7 EBNA-1, -3, -4, -6
EE346-D7 5 EBNA-1, -3, -4, -6EE346 transfectants, revealed up to a sevenfold increase
EE346-D5 5 EBNA-1, -3, -4, -6in pleckstrin RNA and protein levels which was similar
EE346-bulk 6 EBNA-1, -3, -4, -6to its induction in retinoic acid treated HL-60 cells (Tyers
EE3-bulk 1 EBNA-1, -3
et al., 1987). To our knowledge this is the first demonstra- EE4-bulk 1 EBNA-1, -4
tion of the upregulation of pleckstrin by a biological agent EE6-F11 1 EBNA-1, -6
B95-8 7 EBNA-1 to -6, LMP-1, TP-1/2and offers a unique system for studying the regulation
WW2-LCL 10 EBNA-1 to -6, LMP-1, TP-1/2of pleckstrin expression.
BL30A 0 0bSince pleckstrin was not detectable in EBV-negative
dG75 0 0b
cells but expressed in EBV-positive LCLs to similar levels
as in the EE346 transfectants, pleckstrin upregulation by a Quantitated immunoblot signals expressed in relative units.
b 0, contains no EBV genes.the EBNA 3 gene family is consistent with the physiologi-
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phosphoproteins which can bind to DNA via an indirect aiding in the transformation and immortalization of B-
cells by EBV.mechanism, requiring the presence of cellular factors
(Kallin et al., 1986; Sample and Parker, 1994). Recent
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